The big question is why they borrowed $7M more than they paid off. They have been selling apartment complexes to raise a few million here and there. Now it looks like some releveraging but without an income asset to back it up.
Seems to me that the opportunity here is to simply streamline the prescription process. A big pharma with multiple drugs in place will certainly have the best systems in place to streamline. They are doing the math.
Interesting. Looks like a very good product, but I wouldn't know what medical buyers think. It would be nice to see some sales wins. If so, RVP may be worth a few bucks even without the lawsuit income.
We have no reason to believe the BDX even offered a reasonable settlement. We do know they are bullies and arrogant. They may have offered $5M or something silly.
I'm sure it is fine to hold onto. I just read an article about people in Phoenix paying $1000 per month to live in fixed up shipping containers.
That is such a dangling non-statement. Does is mean anything at all? Did they smile and wave at each other? Or did LCI just smile and wave at the customer? Did the customer notice?
Brad Thomas wrote an article on S ee king A lph a today. He has been pretty down on IRT in the past, but gave it a "buy" today. Said basically it is higher risk higher return, but metrics going in the right direction.
It does look like a nice product. I had a neighbor who is a nurse and dropped a needle that jabbed him in the toe through his shoe. It hit a blood vessel and caused some kind of reaction. His food swelled up and he almost lost it after a few weeks. Couldn't work for a long time. Never would have happened with a retractable.
I hope they don't raise the dividend, but rather use the cash to pay down debt. Get the debt/equity down to about 50% and IRT will be a serious REIT.
ANAC is just moving with the rest of the bios. IBB would be much safer to play imo. I think ANAC's crisaborole is going to be much smaller than expected considering all the competition coming on. Crisaborole PIII results really are not much to get excited about when an over the counter ointment, TrueLipids, had 81-87% improvement when used twice daily in mild atopic dermatitis at two weeks...no prescription required.
Some big lots going through at the close. Just the opposite of a couple weeks ago. Looks like someone is selling in the low $6s and buying back over $7.